Intrinsic STING of CD8+T Cells Regulates SelfMetabolic Reprogramming and Improves Anti-Tumor Effects

被引:0
|
作者
Xu, Q. [1 ]
Hua, X. [1 ]
Li, B. [2 ]
Jiang, B. [2 ]
Xu, R. [3 ]
Lv, T. [4 ]
Song, Y. [1 ]
机构
[1] Southeast Univ, Nanjing, Peoples R China
[2] Nanjing Univ Tradit Chinese Med, Nanjing, Peoples R China
[3] Univ Nottingham, Nottingham, England
[4] Nanjing Univ, Nanjing, Jiangsu, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1.02C.01
引用
收藏
页码:S146 / S147
页数:2
相关论文
共 50 条
  • [41] REPROGRAMMING OF MICROGLIA/MACROPHAGES IN GLIOBLASTOMA IMPROVES ANTI-TUMOR T CELL RESPONSES
    Fermi, Valentina
    Warta, Rolf
    Rapp, Carmen
    Trong, Philip Dao
    Jungwirth, Gerhard
    Andreas, Unterberg
    Herold-Mende, Christel
    NEURO-ONCOLOGY, 2022, 24 : 136 - 136
  • [42] Uncoupling protein 2 regulates metabolic reprogramming and fate of antigen-stimulated CD8+T cells
    Chaudhuri, Leena
    Srivastava, Rupesh K.
    Kos, Ferdynand
    Shrikant, Protul A.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2016, 65 (07) : 869 - 874
  • [43] Dgat1 camouflages sexual dimorphism in anti-tumor CD8+T cell immunity
    Madi, Alaa
    Cui, Guoliang
    CANCER IMMUNOLOGY RESEARCH, 2023, 11 (12)
  • [44] Inhibition of Glycolytic Flux Enhances CD8+T Cell Memory, Stemness and Anti-tumor Function
    Sukumar, Madhusudhanan
    Liu, Jie
    Ji, Yun
    Roychoudhuri, Rahul
    Yu, Zhiya
    Klebanoff, Christopher
    Finkel, Toren
    Restifo, Nicholas
    Gattinoni, Luca
    JOURNAL OF IMMUNOTHERAPY, 2012, 35 (09) : 766 - 766
  • [45] Microenvironment-driven metabolic adaptations guiding CD8+T cell anti-tumor immunity
    Park, Jaeoh
    Hsueh, Pei -Chun
    Li, Zhiyu
    Ho, Ping-Chih
    IMMUNITY, 2023, 56 (01) : 32 - 42
  • [46] A novel immunocytokine generates a CD8+T cell-mediated anti-tumor response in vivo
    Fallon, Jonathan K.
    Tighe, Robert
    Strittmatter, Wolfgang
    Sabzevari, Helen
    Schlom, Jeffrey
    Greiner, John W.
    CANCER RESEARCH, 2012, 72
  • [47] A microbial-based cancer vaccine for induction of EGFRvIII-specific CD8+T cells and anti-tumor immunity
    Zebertavage, Lauren
    Bambina, Shelly
    Shugart, Jessica
    Alice, Alejandro
    Zens, Kyra D.
    Lauer, Peter
    Hanson, Bill
    Gough, Michael J.
    Crittenden, Marka R.
    Bahjat, Keith S.
    PLOS ONE, 2019, 14 (01):
  • [48] IL-18 enhances anti-tumor effect of memory CD8+T cells by augmenting metabolic activity and function
    Li, Wen
    Takai, Shinji
    Jing, Denan
    Yamanishi, Kyosuke
    Yamanishi, Hiromichi
    Okamura, Haruki
    CANCER SCIENCE, 2023, 114 : 385 - 385
  • [49] NLRC5 potentiates anti-tumor CD8+T cells responses by activating interferon-β in endometrial cancer
    Zhang, Jing
    Guo, Bao
    Chen, Jia-Hua
    Liu, Xiao-Jing
    Zhang, Jun-Hui
    Zhu, Hai-Qing
    Wang, Wen-Yan
    Tang, Zhen-Hai
    Wei, Bing
    Cao, Yun-Xia
    Zhan, Lei
    TRANSLATIONAL ONCOLOGY, 2023, 36
  • [50] PIK3IP1/TRIP IMMUNE REGULATION ON CD8+T CELLS RESTRICTS ANTI-TUMOR IMMUNITY
    Murter, Benjamin
    Banerjee, Hridesh
    Szymczak-Workman, Andrea
    Kane, Lawrence
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A668 - A668